Rating Change
Leerink Partners reiterated its Market Perform rating on DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on October 14, 2026.
Leerink Partners reiterated its Market Perform rating on DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on October 14, 2026.

At publication ·
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) · reiterate
At a glance
Leerink Partners reiterated its Market Perform rating on DENTSPLY SIRONA Inc. (NASDAQ:XRAY) on October 14, 2026.
DENTSPLY SIRONA Inc. operates in the Healthcare sector. The stock currently trades at $8.44 with a market capitalization of $2.3B. The stock has declined 28.1% over the past 52 weeks.
Analyst coverage from Leerink Partners provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for DENTSPLY SIRONA Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 1 Buy, 6 Hold, 3 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 14, 2026 | Leerink Partners | Market Perform | N/A |
| Oct 09, 2026 | Piper Sandler | Neutral | N/A |
| Sep 17, 2026 | BMO Capital | Market Perform | N/A |
| Aug 24, 2026 | Barclays | Underweight | N/A |
| Jul 29, 2026 | Piper Sandler | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View XRAY Stock Page
A rating of Market Perform from Leerink Partners reflects the analyst's outlook on DENTSPLY SIRONA Inc. (NASDAQ:XRAY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the XRAY forecast page.
Current market data
NASDAQ · XRAY
$8.87
Up: +$0.45 · +5.34%
Live quote updated
Keep reading